Home › Treatment-Resistant Depressive Disorder › Massachusetts
Pag-aaral pangklinika para sa Treatment-Resistant Depressive Disorder sa Massachusetts
7 pag-aaral para sa Treatment-Resistant Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa Massachusetts.
Mga Lungsod sa Massachusetts
Opisyal na teksto ng pag-aaral (English)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Adams Clinical, Inc., Watertown
- Vitalix Clinical, Inc., Worcester
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07284667One-Day cTBS Over the Precuneus
- McLean Hospital, Belmont
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07758010Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Nagre-recruit
Edad 22 hanggang 70 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06423430Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
- Massachusetts General Hospital's Depression and Clinical Research program, Boston
- Massachusetts General Hospital, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT07563868A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Massachusetts General Hospital, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Elixia MA, Springfield
- Adams Clinical, Watertown
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 11, 2026 · NCT06524830ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7166, Worcester
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT07553637Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.